Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,736
Total Claims
$639K
Drug Cost
704
Beneficiaries
$908
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+44%
Opioid rate vs peers
59.4% vs 41.3% avg
+128%
Cost per patient vs peers
$908 vs $399 avg
+79%
Brand preference vs peers
6.7% vs 3.8% avg
Opioid Prescribing
59.4%
Opioid Rate
5,781
Opioid Claims
$492K
Opioid Cost
20.7%
Long-Acting Rate
This provider's opioid prescribing rate of 59.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 653 claims · $319K
Generic: 9,083 claims · $321K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 167 | $136K |
| Hydrocodone/Acetaminophen | 2,573 | $79K |
| Buprenorphine | 213 | $78K |
| Oxycodone Hcl/Acetaminophen | 1,360 | $63K |
| Oxycodone Hcl | 100 | $52K |
| Oxycodone Myristate | 44 | $27K |
| Naloxone Hcl | 280 | $25K |
| Suvorexant | 33 | $15K |
| Naloxegol Oxalate | 31 | $12K |
| Buprenorphine | 18 | $12K |
| Gabapentin | 689 | $12K |
| Tramadol Hcl | 152 | $12K |
| Pregabalin | 460 | $11K |
| Lidocaine | 24 | $9,018 |
| Morphine Sulfate | 410 | $8,934 |
Prescribing Profile
46
Unique Drugs
12.0
Anomaly Score
Patient Profile
66
Avg Age
64%
Female
1.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About